Virtus LifeSci Biotech Products ETF (BBP)

Assets	$20.96M
Expense Ratio	0.79%
PE Ratio	n/a
Shares Out	350,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	+6.23%

Volume	1,373
Open	60.10
Previous Close	59.92
Day's Range	60.10 - 60.82
52-Week Low	50.43
52-Week High	69.12
Beta	0.61
Holdings	65
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

17.19% of assets

Name	Symbol	Weight
Neurocrine Biosciences, Inc.	NBIX	1.78%
Harmony Biosciences Holdings, Inc.	HRMY	1.75%
Intra-Cellular Therapies, Inc.	ITCI	1.73%
Apellis Pharmaceuticals, Inc.	APLS	1.73%
Ascendis Pharma A/S	ASND	1.73%
Tarsus Pharmaceuticals, Inc.	TARS	1.72%
Agios Pharmaceuticals, Inc.	AGIO	1.70%
TG Therapeutics, Inc.	TGTX	1.69%
Ligand Pharmaceuticals Incorporated	LGND	1.68%
Phathom Pharmaceuticals, Inc.	PHAT	1.67%